Skip to main content
Erschienen in: Rheumatology International 5/2010

01.03.2010 | Original Article

Investigation of calcium crystals in OA knees

verfasst von: Martin Fuerst, L. Lammers, F. Schäfer, O. Niggemeyer, J. Steinhagen, C. H. Lohmann, W. Rüther

Erschienen in: Rheumatology International | Ausgabe 5/2010

Einloggen, um Zugang zu erhalten

Abstract

For studies on matrix mineralization in osteoarthritis (OA), a clear analytical approach is necessary to identify and to quantify mineralization in the articular cartilage. The aim of this study is to develop an effective algorithm to quantify and to identify cartilage mineralization in the experimental setting. Four patients with OA of the knee undergoing total knee replacement and four control patients were included. Cartilage calcification was studied by digital contact radiography (DCR), field emission scanning electron microscopy (FE-SEM) X-ray element analysis and Raman spectroscopy (RS). DCR revealed mineralization in all OA cartilage specimens. No mineralization was observed in the control cartilage. Patient I showed rhomboid shaped crystals with a mean Ca:P molar ratio of 1.04 indicated the presence of calcium pyrophosphate dihydrate (CPPD) crystals, while Patients II, III and IV presented carbonate-substituted hydroxyapatite (HA). RS also showed the presence of CPPD crystals in Patient I while Patients II, III and IV revealed spectra confirming the presence of HA crystals. In the corresponding chondrocyte cell culture analyzed with SEM, the presence of CPPD crystals in the culture of Patient I and HA crystals in the culture of Patient II, III and IV was confirmed. No mineralization was found in the cell culture of the controls. The differentiation between BCP and CPPD crystals plays an important role, and the techniques presented here provide an accurate differentiation of these two types of crystals. For quantification of articular cartilage mineralization, DCR is a simple and accurate method.
Literatur
1.
Zurück zum Zitat Ryan LM, McCarty DJ (1997) Calcium pyrophosphate crystal deposition disease, pseudogout and articular chondrocalcinosis. In: Koopman WJ (ed) Arthritis and allied conditions, 13th edn. Wiliams &Wilkins, Baltimore, pp 2103–2105 Ryan LM, McCarty DJ (1997) Calcium pyrophosphate crystal deposition disease, pseudogout and articular chondrocalcinosis. In: Koopman WJ (ed) Arthritis and allied conditions, 13th edn. Wiliams &Wilkins, Baltimore, pp 2103–2105
2.
Zurück zum Zitat Yavorskyy A, Hernandez-Santana A, McCarthy G, McMahon G (2008) Detection of calcium phosphate crystals in the joint fluid of patients with osteoarthritis—analytic approaches and challenges. Analyst (Lond) 133:302–318. doi:10.1039/b716791a CrossRef Yavorskyy A, Hernandez-Santana A, McCarthy G, McMahon G (2008) Detection of calcium phosphate crystals in the joint fluid of patients with osteoarthritis—analytic approaches and challenges. Analyst (Lond) 133:302–318. doi:10.​1039/​b716791a CrossRef
3.
Zurück zum Zitat Derfus BA, Kurian JB, Butler JJ, Daft LJ, Carrera GF, Ryan LM, Rosenthal AK (2002) The high prevalence of pathologic calcium crystals in preoperative knees. J Rheumatol 29:570–573PubMed Derfus BA, Kurian JB, Butler JJ, Daft LJ, Carrera GF, Ryan LM, Rosenthal AK (2002) The high prevalence of pathologic calcium crystals in preoperative knees. J Rheumatol 29:570–573PubMed
4.
Zurück zum Zitat Halverson PB, McCarty DJ (1986) Patterns of radiographic abnormalities associated with basic calcium phosphate and calcium pyrophosphate dihydrate crystal deposition in the knee. Ann Rheum Dis 45:603–605. doi:10.1136/ard.45.7.603 CrossRefPubMed Halverson PB, McCarty DJ (1986) Patterns of radiographic abnormalities associated with basic calcium phosphate and calcium pyrophosphate dihydrate crystal deposition in the knee. Ann Rheum Dis 45:603–605. doi:10.​1136/​ard.​45.​7.​603 CrossRefPubMed
5.
Zurück zum Zitat Nalbant S, Martinez JA, Kitumnuaypong T, Clayburne G, Sieck M, Schumacher HR Jr (2003) Synovial fluid features and their relations to osteoarthritis severity: new findings from sequential studies. Osteoarthritis Cartilage 11:50–54. doi:10.1053/joca.2002.0861 CrossRefPubMed Nalbant S, Martinez JA, Kitumnuaypong T, Clayburne G, Sieck M, Schumacher HR Jr (2003) Synovial fluid features and their relations to osteoarthritis severity: new findings from sequential studies. Osteoarthritis Cartilage 11:50–54. doi:10.​1053/​joca.​2002.​0861 CrossRefPubMed
6.
7.
Zurück zum Zitat Halverson PB, Cheung HS, Johnson R, Struve J (1998) Simultaneous occurrence of calcium pyrophosphate dihydrate and basic calcium phosphate (hydroxyapatite) crystals in a knee. Clin Orthop Relat Res 257:162–165 Halverson PB, Cheung HS, Johnson R, Struve J (1998) Simultaneous occurrence of calcium pyrophosphate dihydrate and basic calcium phosphate (hydroxyapatite) crystals in a knee. Clin Orthop Relat Res 257:162–165
8.
11.
Zurück zum Zitat Derfus B, Kranendonk S, Camacho N, Mandel N, Kushnaryov V, Lynch K, Ryan L (1998) Human osteoarthritis cartilage matrix vesicles generate both calcium pyrophosphate dihydrate and apatite in vitro. Calcif Tissue Int 63(3):258–262. doi:10.1007/s002239900523 CrossRefPubMed Derfus B, Kranendonk S, Camacho N, Mandel N, Kushnaryov V, Lynch K, Ryan L (1998) Human osteoarthritis cartilage matrix vesicles generate both calcium pyrophosphate dihydrate and apatite in vitro. Calcif Tissue Int 63(3):258–262. doi:10.​1007/​s002239900523 CrossRefPubMed
12.
Zurück zum Zitat Johnson K, Moffa A, Chen Y, Pritzker K, Goding J, Terkeltaub R (1999) Matrix vesicle plasma cell membrane glycoprotein-1 regulates mineralization by murine osteoblastic MC3T3 cells. J Bone Miner Res 14:833–892. doi:10.1359/jbmr.1999.14.6.883 CrossRef Johnson K, Moffa A, Chen Y, Pritzker K, Goding J, Terkeltaub R (1999) Matrix vesicle plasma cell membrane glycoprotein-1 regulates mineralization by murine osteoblastic MC3T3 cells. J Bone Miner Res 14:833–892. doi:10.​1359/​jbmr.​1999.​14.​6.​883 CrossRef
13.
Zurück zum Zitat Gajjeraman S, Narayanan K, Hao J, Qin C, George A (2007) Matrix macromolecules in hard tissue control the nucleation and hierarchical assembly of hydroxyapatite. J Biol Chem 282(2):1193–1204CrossRefPubMed Gajjeraman S, Narayanan K, Hao J, Qin C, George A (2007) Matrix macromolecules in hard tissue control the nucleation and hierarchical assembly of hydroxyapatite. J Biol Chem 282(2):1193–1204CrossRefPubMed
16.
Zurück zum Zitat Russell RGG, Bisaz S, Fleisch H, Currey HL, Rubinstein HM, Dietz AA, Boussina I, Micheli A, Falet G (1970) Inorganic pyrophosphate in plasma, urine, and synovial fluid of patients with pyrophosphate arthropathie (chondrocalcinosis or pseudogout). Lancet 2:899–902. doi:10.1016/S0140-6736(70)92070-2 CrossRefPubMed Russell RGG, Bisaz S, Fleisch H, Currey HL, Rubinstein HM, Dietz AA, Boussina I, Micheli A, Falet G (1970) Inorganic pyrophosphate in plasma, urine, and synovial fluid of patients with pyrophosphate arthropathie (chondrocalcinosis or pseudogout). Lancet 2:899–902. doi:10.​1016/​S0140-6736(70)92070-2 CrossRefPubMed
18.
Zurück zum Zitat Williams CJ, Zhang Y, Timms A, Bonavita G, Caeiro F, Broxholme J et al (2002) Autosomal dominant family calcium pyrophosphate dihydrate deposition disease is caused by mutation in the transmembrane protein ANKH. Am J Hum Genet 71:985–991. doi:10.1086/343053 CrossRefPubMed Williams CJ, Zhang Y, Timms A, Bonavita G, Caeiro F, Broxholme J et al (2002) Autosomal dominant family calcium pyrophosphate dihydrate deposition disease is caused by mutation in the transmembrane protein ANKH. Am J Hum Genet 71:985–991. doi:10.​1086/​343053 CrossRefPubMed
19.
Zurück zum Zitat Hirose J, Ryan LM, Masuda I (2002) Up-regulated expression of cartilage intermediate-layer protein and ANK in articular hyaline cartilage from patients with calcium pyrophosphate dihydrate crystal deposition disease. Arthritis Rheum 46:3218–3229. doi:10.1002/art.10632 CrossRefPubMed Hirose J, Ryan LM, Masuda I (2002) Up-regulated expression of cartilage intermediate-layer protein and ANK in articular hyaline cartilage from patients with calcium pyrophosphate dihydrate crystal deposition disease. Arthritis Rheum 46:3218–3229. doi:10.​1002/​art.​10632 CrossRefPubMed
20.
Zurück zum Zitat Mandel GS, Halverson PB, Rathburn M, Mandel NS (1990) Calcium pyrophosphate crystal deposition: a kinetic study using a type I collagen gel model. Scanning Microsc 4(1):175–179PubMed Mandel GS, Halverson PB, Rathburn M, Mandel NS (1990) Calcium pyrophosphate crystal deposition: a kinetic study using a type I collagen gel model. Scanning Microsc 4(1):175–179PubMed
21.
Zurück zum Zitat McCarthy DJ, Hogan JM, Gatter RA, Grossman M (1966) Studies on pathological calcifications in human cartilage. J Bone Joint Surg 48:309–325 McCarthy DJ, Hogan JM, Gatter RA, Grossman M (1966) Studies on pathological calcifications in human cartilage. J Bone Joint Surg 48:309–325
Metadaten
Titel
Investigation of calcium crystals in OA knees
verfasst von
Martin Fuerst
L. Lammers
F. Schäfer
O. Niggemeyer
J. Steinhagen
C. H. Lohmann
W. Rüther
Publikationsdatum
01.03.2010
Verlag
Springer-Verlag
Erschienen in
Rheumatology International / Ausgabe 5/2010
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-009-1032-2

Weitere Artikel der Ausgabe 5/2010

Rheumatology International 5/2010 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.